Sponsor Dossier

Fresenius Kabi

Sponsor Dossier for Fresenius Kabi. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.

About

Fresenius Kabi is an Australian Private Company with ABN 39109383593, incorporated in NSW and currently active. The company has operated under previous business names including ADDMIX, PHARMATEL MANUFACTURING, and PHARMATEL ONCOLOGY.

Portfolio

Fresenius Kabi has 50 brands on the ARTG, of which 45 are indexable and have Product Information on file. Two brands have PBS-listed items, two brands have PBAC outcomes on record, and three brands have AusPARs on record.

Therapeutic focus

Fresenius Kabi's portfolio spans the following therapeutic areas: — Other (15 brands) — Infectious Disease (11 brands) — Gastroenterology (9 brands) — Oncology (4 brands) — Haematology (3 brands) — Neurology (3 brands) — Pain & Anaesthesia (3 brands) — Cardiology (1 brand) — Women's Health (1 brand)

PBS footprint

Two brands in Fresenius Kabi's portfolio are PBS-listed, with the latest PBS schedule date touched on 2026-05-01.

Regulatory activity

Fresenius Kabi's most recent PBAC outcome was recorded on 2017-11-01 covering two brands, and the most recent AusPAR was published on 2019-11-13 covering three brands.

ABR record